Enquire
Clinical-stage biotech · Cambridge

Medicines for the next generation.

Helix designs precision gene therapies for rare inherited diseases, with two programmes now in clinical trials.

2Programmes in clinic
£186mRaised to date
90Scientists & clinicians
Gene therapyRare diseasePhase IIAAVPrecisionPatients first
The house

2018

Every programme starts with a family waiting for an answer.

Founded by scientists from the University of Cambridge, Helix now employs ninety people across research and clinical development.

What we do

Our pipeline

HLX-10101

HLX-101

Inherited retinal disease. Phase II, enrolling.

2

Programmes in clinic

HLX-204

Rare metabolic disorder. Phase I/II.

HLX-310

HLX-310

Neuromuscular disease. IND-enabling studies.

Platform

Next-generation capsids designed with machine learning.

2Programmes in clinic
£186mRaised to date
90Scientists & clinicians
14Patient groups partnered
In detail

Every detail, considered

Phase IILead programme
AAVDelivery platform
Helix Biotech
GMPManufacturing partner
MHRAApproved trials
Partnerships

Work with Helix

Academic

Research partners

Collaboration

  • Shared IP framework
  • Lab access
  • Joint publications

Commercial

Industry

Licensing

  • Regional rights
  • Co-development
  • Platform access
Clients

Chosen by people who notice the detail

“A partner that treats families as collaborators, not subjects.”

★★★★★  Patient group chair · UK

“Some of the most elegant capsid work I have seen.”

★★★★★  Professor of Genetics · London

“Clear, fast and scientifically rigorous.”

★★★★★  Clinical site lead · Manchester

“A partner that treats families as collaborators, not subjects.”

★★★★★  Patient group chair · UK

“Some of the most elegant capsid work I have seen.”

★★★★★  Professor of Genetics · London

“Some of the most elegant capsid work I have seen.”

★★★★★  Professor of Genetics · London

“Clear, fast and scientifically rigorous.”

★★★★★  Clinical site lead · Manchester

“A partner that treats families as collaborators, not subjects.”

★★★★★  Patient group chair · UK

“Some of the most elegant capsid work I have seen.”

★★★★★  Professor of Genetics · London

“Clear, fast and scientifically rigorous.”

★★★★★  Clinical site lead · Manchester
By appointment

Begin a private conversation

Tell us what you have in mind. A director will reply personally within one working day.